Diagnosis and Management of Pelvic Floor Dysfunction and Fecal Incontinence

Viewing Options

Webcast (online accreditation)

Topic Information

Target Audience

Nurse practitioners and physician assistants involved in the management of patients with GI disorders and chronic liver disease.

Educational Objectives

At the conclusion of this activity, participants will be able to:


Describe current diagnostic approaches for dyssynergic defecation and fecal incontinence

Summarize current management recommendations for dyssynergic defecation and fecal incontinence


Release Date: 11/30/19
Expiration Date: 11/30/20

Accreditation Statement

ANCC Accreditation

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center's Commission on Accreditation.

A maximum of 0.5 contact hours may be earned for successful completion of this activity.

Nurse Practitioner Statement

This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through the joint providership of Annenberg Center for Health Sciences and GI Health Foundation. Annenberg Center for Health Sciences is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 040207.

This program is accredited for 0.5 contact hours. Program ID #5742


Physician Assistant Statement

This activity has been reviewed by the AAPA Review Panel and is compliant with AAPA CME Criteria. This activity is designated for 0.5 AAPA Category 1 CME credits. Approval is valid for one year from 11/30/2019. PAs should only claim credit commensurate with the extent of their participation.



Disclosure of Conflicts of Interest:

All faculty and staff involved in the planning or presentation of continuing education activities provided by the Annenberg Center for Health Sciences at Eisenhower (ACHS) are required to disclose to the audience any real or apparent commercial financial affiliations related to the content of the presentation or enduring material. Full disclosure of all commercial relationships must be made in writing to the audience prior to the activity. Charles Willis, Director of Continuing Education, consults for Pfizer, Inc., John Bayliss, VP, Business Development, Annenberg Center, spouse is an employee of Amgen, Inc; all other staff at the Annenberg Center for Health Sciences at Eisenhower and joint provider name here have no relationships to disclose.

Learner Assurance Statement:

The Annenberg Center for Health Sciences at Eisenhower is committed to resolving all conflicts of interest issues that could arise as a result of prospective faculty members’ significant relationships with drug or device manufacturer(s). The Annenberg Center for Health Sciences at Eisenhower is committed to retaining only those speakers with financial interests that can be reconciled with the goals and educational integrity of the CME activity.

Faculty Disclosures:

Amy Kassebaum, PA-C, MMS, RD
Speakers Bureau: Salix, Clinical Area- IBS-C/CC, IBS-D
Consultant: Salix, Clinical Area- IBS-C/CC, IBS-D
Consultant: Takeda, Clinical Area- CC


This activity is supported by educational grants from: American Regent, Inc., Gilead,Pfizer Inc., Prometheus Laboratories Inc., Salix Pharmaceuticals, and Synergy Pharmaceuticals Inc.

Accredited by

© Copyright 2013-2019 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only. Use of this website is governed by the GIHF terms of use and privacy statement.